BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35968592)

  • 1. [Clinical study of mesenchymal stem cells from third-party donors in the treatment of refractory late onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplanation].
    Zhao K; Huang F; Chen XY; Chang Y; Xu N; Shi PC; Liu H; Sun J; Xiang P; Liu QF; Fan ZP
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):488-493. PubMed ID: 35968592
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy and Safety of MSC Infusion in Treatment of Children with Refractory LOHC: A Clinical Study].
    Qiu KY; Liao XY; Guo SY; Qi HN; Lan JJ; Fang JP; Huang K; Li Y; Xu HG; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):900-904. PubMed ID: 29950240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation.
    Han TT; Xu LP; Liu DH; Liu KY; Fu HX; Zhao XY; Zhao XS; Huang XJ
    Am J Hematol; 2014 Jan; 89(1):55-61. PubMed ID: 24009106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of late-onset hemorrhagic cystitis after allo-HSCT without in vitro T-cell depletion.
    Yuan H; Chen G; Qu J; Yang R; Muhashi M; Aizezi G; Jiang M
    Medicine (Baltimore); 2022 Dec; 101(50):e32130. PubMed ID: 36550833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiological Study of Late Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
    Deng LL; Qiu KY; Liao XY; Liang YW; Huang K; Li Y; Xu HG; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1167-1173. PubMed ID: 30111425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and long-term follow-up of using umbilical cord blood-derived mesenchymal stromal cells in pediatric patients with severe BK virus-associated late-onset hemorrhagic cystitis after unrelated cord blood transplantation.
    Tong J; Liu H; Zheng C; Zhu X; Tang B; Wan X; Yao W; Song K; Zhang L; Zhang X; Sun Z
    Pediatr Transplant; 2020 Mar; 24(2):e13618. PubMed ID: 31944495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
    Wang Y; Chen F; Gu B; Chen G; Chang H; Wu D
    Acta Haematol; 2015; 133(1):72-7. PubMed ID: 25139500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk Factors of Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation].
    Zhang LY; Xiong YY; Liao MY; Xiao Q; Tang XQ; Luo XH; Zhang HB; Wang L; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):250-256. PubMed ID: 38387930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-related late-onset hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation.
    Huang XJ; Liu DH; Xu LP; Zhang HY; Liu KY
    Chin Med J (Engl); 2008 Sep; 121(18):1766-9. PubMed ID: 19080354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of mesenchymal stem cell as salvage treatment for refractory acute graft-versus-host disease].
    Zhao K; Huang F; Peng YW; Zhou HS; Fan ZP; Zhang X; Guo XT; Xu N; Sun J; Xiang P; Liu QF
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):122-6. PubMed ID: 23611218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids.
    Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Ann Hematol; 2018 Jul; 97(7):1209-1217. PubMed ID: 29532160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK Virus Infections and Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Sökmen H; Öztürk G; Çimentepe M; Özen S; Wahhab Alantake HA; Bayram İ; Yarkın F
    New Microbiol; 2023 May; 46(2):141-145. PubMed ID: 37247234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of etiology of hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation].
    Liu DH; Xu LP; Huang XJ; Liu KY; Han W; Chen H; Zhang YC; Chen YH; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):124-7. PubMed ID: 17418022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Keklik M; Deveci B; Celik S; Deniz K; Gonen ZB; Zararsiz G; Saba R; Akyol G; Ozkul Y; Kaynar L; Keklik E; Unal A; Cetin M; Jones OY
    Ann Hematol; 2023 Jun; 102(6):1537-1547. PubMed ID: 37067556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon.
    Ringdén O; Uzunel M; Sundberg B; Lönnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
    Leukemia; 2007 Nov; 21(11):2271-6. PubMed ID: 17611560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
    Onda Y; Kanda J; Hanaoka N; Watanabe M; Arai Y; Hishizawa M; Kondo T; Yamashita K; Nagao M; Fujimoto T; Takaori-Kondo A
    Ann Hematol; 2021 Mar; 100(3):753-761. PubMed ID: 33439306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.